BioScience Health Innovations, Inc. (BHIC)

Market Cap	24.15M
Revenue (ttm)	5.69M +208.3%
Net Income	642.09K +638.0%
EPS	0.06 +604.8%
Shares Out	10.98M
PE Ratio	37.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	3,253
Open	2.200
Previous Close	2.082
Day's Range	2.200 - 2.200
52-Week Range	0.520 - 4.000
Beta	0.36
RSI	49.91
Earnings Date	May 5, 2026

About BHIC

BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses in the United States. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac a...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• CEO: Darren Lopez
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BHIC

Financial Performance

In 2025, BHIC's revenue was $5.69 million, an increase of 208.34% compared to the previous year's $1.84 million. Earnings were $642,090, an increase of 638.03%.